Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

Yasuo Mori; Goichi Yoshimoto; Jun Ichiro Yuda; Masayasu Hayashi; Jun Odawara; Takuro Kuriyama; Takeshi Sugio; Kohta Miyawaki; Kenjiro Kamezaki; Koji Kato; Katsuto Takenaka; Hiromi Iwasaki; Takahiro Maeda; Toshihiro Miyamoto; Koichi Akashi

doi:10.1080/10428194.2018.1466295

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

Yasuo Mori, Goichi Yoshimoto, Jun Ichiro Yuda, Masayasu Hayashi, Jun Odawara, Takuro Kuriyama, Takeshi Sugio, Kohta Miyawaki, Kenjiro Kamezaki, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Takahiro Maeda, Toshihiro Miyamoto, Koichi Akashi

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	271-273
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	60
Issue number	1
DOIs	https://doi.org/10.1080/10428194.2018.1466295
Publication status	Published - Jan 2 2019

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2018.1466295

Cite this

Mori, Y., Yoshimoto, G., Yuda, J. I., Hayashi, M., Odawara, J., Kuriyama, T., Sugio, T., Miyawaki, K., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T., & Akashi, K. (2019). Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation. Leukemia and Lymphoma, 60(1), 271-273. https://doi.org/10.1080/10428194.2018.1466295

Mori, Y, Yoshimoto, G, Yuda, JI, Hayashi, M, Odawara, J, Kuriyama, T, Sugio, T, Miyawaki, K, Kamezaki, K, Kato, K, Takenaka, K, Iwasaki, H, Maeda, T, Miyamoto, T & Akashi, K 2019, 'Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation', Leukemia and Lymphoma, vol. 60, no. 1, pp. 271-273. https://doi.org/10.1080/10428194.2018.1466295

@article{27fde151093c47a78ea3e1ec606fe935,

title = "Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation",

author = "Yasuo Mori and Goichi Yoshimoto and Yuda, {Jun Ichiro} and Masayasu Hayashi and Jun Odawara and Takuro Kuriyama and Takeshi Sugio and Kohta Miyawaki and Kenjiro Kamezaki and Koji Kato and Katsuto Takenaka and Hiromi Iwasaki and Takahiro Maeda and Toshihiro Miyamoto and Koichi Akashi",

year = "2019",

month = jan,

day = "2",

doi = "10.1080/10428194.2018.1466295",

language = "English",

volume = "60",

pages = "271--273",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

AU - Mori, Yasuo

AU - Yoshimoto, Goichi

AU - Yuda, Jun Ichiro

AU - Hayashi, Masayasu

AU - Odawara, Jun

AU - Kuriyama, Takuro

AU - Sugio, Takeshi

AU - Miyawaki, Kohta

AU - Kamezaki, Kenjiro

AU - Kato, Koji

AU - Takenaka, Katsuto

AU - Iwasaki, Hiromi

AU - Maeda, Takahiro

AU - Miyamoto, Toshihiro

AU - Akashi, Koichi

PY - 2019/1/2

Y1 - 2019/1/2

UR - http://www.scopus.com/inward/record.url?scp=85046676639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046676639&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1466295

DO - 10.1080/10428194.2018.1466295

M3 - Letter

C2 - 29741437

AN - SCOPUS:85046676639

SN - 1042-8194

VL - 60

SP - 271

EP - 273

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 1

ER -

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this